Table 4.
Epinephrine-induced platelet aggregation a Coef [95% CI]; p value c |
Epinephrine-induced ATP secretion b Coef d |
|||||
---|---|---|---|---|---|---|
ODI ≥15 (ref ODI <15) | AUC | Amp | Rate | AUC | Amp | Rate |
Univariate | −86.73 [−149.8,−23.7] p=0.009 | −30.82 [−52.2,−9.4] p=0.006 | −22.6 [−39.6,−5.6] p=0.011 | −0.63 | −0.29 | −9.56 |
Adjusted for BMI & BP | −58.37 [−133.7,16.9] p=0.123 | −24.8 [−51.6,2] p=0.069 | −22.49 [−43.5,−15] p=0.037 | −0.61 | −0.3 | −9.89 |
Adjusted for fasting glucose & HDL | −82.46 [−173.8,8.8] p=0.075 | −32.7 [−63.2,−2.2] p=0.036 | −24.61 [−51.2,1.9] p=0.068 | −0.36 | −0.22 | −7.17 |
Adjusted for BMI, BP, fasting glucose & HDL | −62.06 [−162.8,38.7] p=0.213 | −30.04 [−65.5,5.4] p=0.092 | −19.53 [−49.7,10.6] p=0.191 | −0.35 | −0.24 | −8.42 |
Thrombin-induced platelet aggregation a Coef [95% CI]; p value c or Coef d |
Thrombin-induced ATP secretion b Coef [95% CI]; p value c or Coef d |
|||||
ODI ≥15 (ref ODI <15) | AUC | Amp | Rate | AUC | Amp | Rate |
Univariate | −90.51 [−171.9,−9.1] p=0.03 | −14.27 [−28.7,0.1] p=0.052 | −59.07 [−128.5,10.4] p=0.092 | 0.03 | 0.06 | 12.98 |
Adjusted for BMI & BP | −41.39 [−121.8,39] p=0.298 | −3.35 [−15.7,9] p=0.58 | −15.41 [−76.2,45.4] p=0.605 | −0.64 | −0.1 | −0.31 [−30.1,29.5] p=0.983 |
Adjusted for fasting glucose & HDL | −21.96 | −579 | −36.32 | 0.17 | 0.07 | 11.85 |
Adjusted for BMI, BP, fasting glucose & HDL | 44.35 [−56.9,145.7] p=0.371 | 7.9 | 28.23 | −0.64 | −0.14 [−0.8,0.5] p=0.648 | 2.52 [−41.8,46.8] p=0.907 |
ODI, oxygen desaturation index; Coef, coefficient; CI, confidence interval; BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein cholesterol.
Coef indicates the mean change in outcome variable among ODI ≥15 vs. ODI <15 in crude unadjusted and adjusted models, where adjustment is done by adding BMI and BP, fasting glucose and HDL cholesterol, or all 4 factors to the model.
AUC, area under the curve (%*min); amp, amplitude (%); rate, rate (slope) (%/min).
AUC, area under the curve (nanomoles*min); amp, amplitude (nanomoles); rate, rate (slope) (nanomoles/min).
In cases where non-normality of residuals was not detected, coefficient and inference are both valid and shown.
In cases where non-normality of residuals was detected, only coefficient is valid and shown.